Evidence map›Paper›PMID 42131115›Full record

ArticleJournal of otology2026

Identification of Novel

Kun Zhang, Xijian Xin, Shiqi Huang, Bo Hou, Xinbo Xu, Peng Qu, Xiao Han, Hanbing Zhang

Abstract read
PubMed Full text at PMC Publisher
In one paragraph

Article in Journal of otology, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.

0numbers the graph read from it
0cells of the map it votes in
0citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

0 citing papers in PubMed.

No citing paper in PubMed yet.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

8 authors.

Kun ZhangDepartment of Otorhinolaryngology, Qilu Hospital of Shandong University, Jinan, Shandong, China.
Xijian XinDepartment of Otorhinolaryngology, Qilu Hospital of Shandong University, Jinan, Shandong, China.
Shiqi HuangDepartment of Otorhinolaryngology, Qilu Hospital of Shandong University, Jinan, Shandong, China.
Bo HouDepartment of Otorhinolaryngology, Qilu Hospital of Shandong University, Jinan, Shandong, China.
Xinbo XuDepartment of Otorhinolaryngology, Qilu Hospital of Shandong University, Jinan, Shandong, China.
Peng QuDermatology Hospital of Shandong First Medical University, Jinan, Shandong, China.
Xiao HanDepartment of Otorhinolaryngology, Qilu Hospital of Shandong University, Jinan, Shandong, China.
Hanbing ZhangDepartment of Otorhinolaryngology, Qilu Hospital of Shandong University, Jinan, Shandong, China.

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Objectives: Although Method: In this study, we conducted targeted whole-exome sequencing along with Sanger sequencing on 157 probands with non-syndromic hearing loss, as well as their family members. We identified novel variants in the Results: In this study, potential causal variants were identified in 95 (60.51%) affected individuals and variants in SLC26A4 and GJB2 were most frequent in this cohort. we identified ten different variants in the Conclusions: We have identified five novel variants of the

Indexed as

cochlear implantsLOXHD1nonsyndromic hearing lossvariantwhole-exome sequencing

Identifiers

PMID42131115
PMCPMC13162036

What OpenQuestion holds

Textmetadata
LicenceCC BY-NC-ND
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.